The Latest on Melanoma and Treatment - Part 2: Importance of Clinical Trials

Jeff Infante, M.D.

The Latest on Melanoma and Treatment - Part 2: Importance of Clinical Trials

Jeff Infante, M.D., Director of Drug Development Unit at Sarah Cannon Research Institute and Medical Oncologist at Tennessee Oncology, discusses clinical trials as a treatment option for melanoma. The advancements seen through clincial trials have greatly improved the number of effective cancer  drugs available for advanced stages of melanoma especially.

Watch the next video in the series: The Latest on Melanoma and Treatment—Part 3: Advances in Targeted Therapy